Table I.
Association between GOLPH3 expression and the clinicopathological features of 60 patients with non-small cell lung cancer.
| Expression of GOLPH3 | ||||
|---|---|---|---|---|
| Variables | Number of patients | Low (n=32) | High (n=28) | P-value |
| Age, years | 0.128 | |||
| <60 | 32 | 20 | 12 | |
| ≥60 | 28 | 12 | 16 | |
| Tumor invasion depth, cm | 0.464 | |||
| <5 | 20 | 12 | 8 | |
| ≥5 | 40 | 20 | 20 | |
| Lymph node metastasis | 0.005 | |||
| With | 43 | 18 | 25 | |
| Without | 17 | 14 | 3 | |
| Distant metastasis | 0.002 | |||
| With | 24 | 7 | 17 | |
| Without | 36 | 25 | 11 | |
| Pathological type | 0.796 | |||
| Adenocarcinoma | 30 | 16 | 14 | |
| Squamous cell carcinoma | 30 | 15 | 15 | |
| Sex | 0.267 | |||
| Male | 43 | 21 | 22 | |
| Female | 17 | 11 | 6 | |
GOLPH3, Golgi phosphoprotein 3.